JPWO2021087093A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021087093A5
JPWO2021087093A5 JP2022524112A JP2022524112A JPWO2021087093A5 JP WO2021087093 A5 JPWO2021087093 A5 JP WO2021087093A5 JP 2022524112 A JP2022524112 A JP 2022524112A JP 2022524112 A JP2022524112 A JP 2022524112A JP WO2021087093 A5 JPWO2021087093 A5 JP WO2021087093A5
Authority
JP
Japan
Prior art keywords
aryl
alkyl
membered
group
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022524112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500611A5 (https=
JP2023500611A (ja
JP7720833B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/057930 external-priority patent/WO2021087093A1/en
Publication of JP2023500611A publication Critical patent/JP2023500611A/ja
Publication of JPWO2021087093A5 publication Critical patent/JPWO2021087093A5/ja
Publication of JP2023500611A5 publication Critical patent/JP2023500611A5/ja
Application granted granted Critical
Publication of JP7720833B2 publication Critical patent/JP7720833B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022524112A 2019-10-30 2020-10-29 Heliosの低分子分解誘導剤および使用方法 Active JP7720833B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962928139P 2019-10-30 2019-10-30
US62/928,139 2019-10-30
US202063035272P 2020-06-05 2020-06-05
US63/035,272 2020-06-05
US202063047411P 2020-07-02 2020-07-02
US63/047,411 2020-07-02
PCT/US2020/057930 WO2021087093A1 (en) 2019-10-30 2020-10-29 Small molecule degraders of helios and methods of use

Publications (4)

Publication Number Publication Date
JP2023500611A JP2023500611A (ja) 2023-01-10
JPWO2021087093A5 true JPWO2021087093A5 (https=) 2023-10-30
JP2023500611A5 JP2023500611A5 (https=) 2023-10-30
JP7720833B2 JP7720833B2 (ja) 2025-08-08

Family

ID=75715607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022524112A Active JP7720833B2 (ja) 2019-10-30 2020-10-29 Heliosの低分子分解誘導剤および使用方法

Country Status (16)

Country Link
US (1) US20230002397A1 (https=)
EP (1) EP4051386A4 (https=)
JP (1) JP7720833B2 (https=)
KR (1) KR20220092920A (https=)
CN (1) CN114650868A (https=)
AU (1) AU2020374957A1 (https=)
BR (1) BR112022007867A2 (https=)
CA (1) CA3154942A1 (https=)
CL (1) CL2022001111A1 (https=)
CR (1) CR20220234A (https=)
DO (1) DOP2022000091A (https=)
IL (1) IL292173A (https=)
MX (1) MX2022005232A (https=)
PE (1) PE20221457A1 (https=)
PH (1) PH12022550980A1 (https=)
WO (1) WO2021087093A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20220234A (es) * 2019-10-30 2022-07-19 Dana Farber Cancer Inst Inc Degradadores de moléculas pequeñas de helios y procedimientos de uso
AU2020387392B2 (en) 2019-11-19 2025-09-11 Bristol-Myers Squibb Company Compounds useful as inhibitors of Helios protein
US20230271940A1 (en) * 2020-08-03 2023-08-31 Novartis Ag Heteroaryl substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
IL301690A (en) * 2020-10-16 2023-05-01 Dana Farber Cancer Inst Inc Piperidinyl small molecule degraders of helios and methods of use
EP4452415B1 (en) 2021-12-22 2026-02-25 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
CN118401512A (zh) * 2021-12-24 2024-07-26 苏州开拓药业股份有限公司 一种具有酰亚胺骨架的多蛋白降解剂
CN116640122A (zh) * 2022-02-16 2023-08-25 苏州国匡医药科技有限公司 Ikzf2降解剂及包含其的药物组合物和用途
CA3253296A1 (en) 2022-03-17 2023-09-21 Gilead Sciences, Inc. Zinc Finger Degradation Agents of the Ikaros Family and Their Uses
WO2023183540A1 (en) * 2022-03-25 2023-09-28 Regents Of The University Of Michigan Ikzf2 degraders and uses thereof
WO2023201012A1 (en) * 2022-04-15 2023-10-19 Regents Of The University Of Michigan Ikzf2 degraders and uses thereof
CN119013270A (zh) * 2022-04-29 2024-11-22 西藏海思科制药有限公司 一种含氮杂环衍生物及其组合物和药学上的应用
EP4570792A1 (en) * 2022-08-10 2025-06-18 Gluetacs Therapeutics (Shanghai) Co., Ltd. Compound based on isoindoline-substituted glutarimide backbone and use thereof
WO2024073871A1 (en) * 2022-10-04 2024-04-11 Biofront Ltd Gspt1 degraders, compositions comprising the degrader, and methods of using the same
JP2025537123A (ja) * 2022-11-11 2025-11-14 ニカング セラピューティクス, インコーポレイテッド ユビキチンプロテアソーム経路を介してサイクリン依存性キナーゼ2を分解するための2,5-置換ピリミジン誘導体を含有する二官能性化合物
WO2024109918A1 (zh) * 2022-11-24 2024-05-30 西藏海思科制药有限公司 一种gspt1降解剂及其在医药上的应用
WO2024222918A1 (zh) * 2023-04-28 2024-10-31 中国药科大学 一种苯并六元杂环类gspt1蛋白降解剂及其应用
WO2025011624A1 (en) * 2023-07-11 2025-01-16 Etern Biopharma (Shanghai) Co., Ltd. Bifunctional compounds for androgen receptor degradation and methods of use
CN121532386A (zh) * 2023-07-28 2026-02-13 杭州中美华东制药有限公司 具有蛋白降解作用的芳胺类化合物
WO2025097092A1 (en) * 2023-11-02 2025-05-08 Neomorph, Inc. Substituted 3-(5-(4-hydroxypiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and 3-(2-(4-hydroxypiperidin-4-yl)-5-oxo-5,7-dihydro-6h-pyrrolo[3,4-b]pyridin-6-yl)piperidine-2,6-dione derivatives and uses thereof
WO2025245178A1 (en) * 2024-05-21 2025-11-27 Innovo Therapeutics, Inc. Pak4, cstf2, or cstf2t protein degraders, pharmaceutical compositions, and therapeutic applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012268036B2 (en) * 2011-06-06 2017-04-06 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS Methods of inhibiting muscle atrophy
TWI793151B (zh) * 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
JP7585034B2 (ja) * 2017-10-18 2024-11-18 ノバルティス アーゲー 選択的タンパク質分解のための組成物及び方法
EP3924055B1 (en) * 2019-02-15 2024-04-03 Novartis AG Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
CN113490528B (zh) * 2019-02-15 2024-12-03 诺华股份有限公司 3-(1-氧代-5-(哌啶-4-基)异吲哚啉-2-基)哌啶-2,6-二酮衍生物及其用途
WO2020168172A1 (en) * 2019-02-15 2020-08-20 Zamboni Chem Solutions Inc. Conjugate compounds for the degradation of raf
CR20220234A (es) * 2019-10-30 2022-07-19 Dana Farber Cancer Inst Inc Degradadores de moléculas pequeñas de helios y procedimientos de uso
KR20220147109A (ko) * 2020-02-27 2022-11-02 노파르티스 아게 키메라 항원 수용체 발현 세포의 제조 방법
CN115916199A (zh) * 2020-06-23 2023-04-04 诺华股份有限公司 包含3-(1-氧代异吲哚啉-2-基)哌啶-2,6-二酮衍生物的给药方案
IL301690A (en) * 2020-10-16 2023-05-01 Dana Farber Cancer Inst Inc Piperidinyl small molecule degraders of helios and methods of use
CN117355299A (zh) * 2021-04-29 2024-01-05 尼奥莫夫公司 取代的2-(2,6-二氧代哌啶-3-基)-5-(1-哌啶-4-基)异吲哚啉-1,3-二酮衍生物及其用途
CA3209633A1 (en) * 2021-04-29 2022-11-03 Tinghu Zhang Phthalimido cereblon complex binders and transcription factor degraders and methods of use

Similar Documents

Publication Publication Date Title
JPWO2021087093A5 (https=)
JP2020537657A5 (https=)
JP2020505396A5 (https=)
JP2005504042A5 (https=)
JP2005524628A5 (https=)
JP2019518741A5 (https=)
JP2018516238A5 (https=)
JP2011509309A5 (https=)
WO2005113537B1 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
CA2410662A1 (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
JPWO2022081976A5 (https=)
JP2013209405A5 (https=)
JPWO2019226761A5 (https=)
JP2020507566A5 (https=)
JP2021535159A5 (https=)
RU2215000C2 (ru) Производные солей пиридиния, способ их получения, фармацевтические композиции на их основе и способы лечения
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2002515427A5 (https=)
JPWO2020160295A5 (https=)
JPWO2022140316A5 (https=)
JP2020519659A5 (https=)
RU2003130644A (ru) Производные ркарболина и их фармацевтическое применение против дипрессии и страха
JP2005511535A5 (https=)
JP2002523496A5 (https=)
JP2006514051A5 (https=)